Neuropilin-1
-
Subject Areas on Research
- Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
- Metabolism and vascular fatty acid transport.
- MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
- Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding.
- Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
- Protein profile of exosomes from trabecular meshwork cells.
- Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma.
- VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.